Dr. Hsieh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-456-8068Fax+1 714-456-3765
Education & Training
- University of California (Irvine)Residency, Internal Medicine, 1999 - 2002
- New York University School of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2001 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1866 citationsRemdesivir for the Treatment of Covid-19 - Final Report.John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman
The New England Journal of Medicine. 2020-11-05 - 45 citationsGenome-Wide B Cell, CD4 + , and CD8 + T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preem...Swayam Prakash, Ruchi Srivastava, Pierre-Gregoire A Coulon, Nisha R Dhanushkodi, Aziz Alami Chentoufi
Journal of Immunology. 2021-06-01 - 73 citationsA Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.Antoney Ferrey, Grace Choi, Ramy M Hanna, Yongen Chang, Ekamol Tantisattamo
American Journal of Nephrology. 2020-03-28
Journal Articles
- Remdesivir for the Treatment of Covid-19 — Final ReportAneesh K Mehta, Barry S Zingman, Andre C Kalil, Helen Y Chu, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Daniel A Sweeney, Willia..., The New England Journal of Medicine
Press Mentions
- Should the FDA Have Approved Remdesivir to Treat COVID-19 Patients?October 26th, 2020
- University of California Researchers Will Test Former Ebola Drug as Part of Coronavirus Clinical TrialMarch 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: